Moxifloxacin (Avelox) for the treatment of bacterial skin infections.

Abstract

Moxifloxacin (Avelox, Bayer), which is available for oral administration, is a broad-spectrum synthetic antimicrobial agent with excellent Gram-positive activity and good Gram-negative activity. The US FDA recently approved this drug for the treatment of bacterial skin infections.

Cite this paper

@article{Parish2001MoxifloxacinF, title={Moxifloxacin (Avelox) for the treatment of bacterial skin infections.}, author={Lawrence Charles Parish and Joseph A Witkowski and Hirak B Routh}, journal={Skin therapy letter}, year={2001}, volume={6 11}, pages={1-2} }